ReviewCells2025

High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies.

Danilo De Novellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.